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ABSTRACT 
Positron emission tomography (PET) and computed tomography (CT) together are a 
powerful diagnostic tool, but imperfect image quality contributes to false positive and false 
negative diagnoses by an observer despite experience and training.  This work investigated a 
PET standard uptake value (SUV) correction scheme, based on partial volume effect (PVE), on 
the classification of lesions as benign or malignant in PET/CT images.   
The correction scheme comprised several steps.  The observer drew a region of interest 
(ROI) around the lesion using the CT dataset.  The ROI was blurred with the assumed point 
spread function (PSF) of the PET scanner then re-sampled to the PET voxel size.  The magnitude 
of the ROI-based PVE was used as a scaling factor to correct the lesion’s tumor-to-background 
ratio (TBR), which was used as a surrogate for SUV in the PET images of the phantom.  
Computer simulations showed that the accuracy of the correction depends strongly on the 
accuracy of the ROI drawn on the CT images, especially for small lesions.  Correction accuracy 
was affected slightly by mismatch of the simulation PSF to the actual scanner PSF.  A receiver 
operating characteristic (ROC) study, using phantom data, was performed to evaluate the effect 
of the correction scheme on diagnostic performance.  The correction scheme significantly 
increased sensitivity and slightly increased accuracy for all acquisition and reconstruction modes 
at the cost of a small decrease in specificity.  Corrected TBRs more accurately represented actual 
TBRs than uncorrected TBRs.  The observer study also found that, when using PET data alone, 
3D ordered subset expectation maximization (OSEM) outperformed 3D filtered back-projection 
(FBP), 2D OSEM, and 2D FBP in terms of sensitivity, specificity, and area-under-the-ROC-
curve values.  However, when PET data was displayed with correlated CT data, with and without 
PVE correction, no combination of reconstruction algorithm and acquisition mode outperformed 
any other.
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CHAPTER 1:   
INTRODUCTION 
The purpose of this study was to evaluate the effect of a standard uptake value (SUV) 
correction scheme, based on partial volume effect (PVE), on the accuracy of classification in 
terms of malignancy of single pulmonary nodules in positron emission tomography (PET) / 
computed tomography (CT) images.  PET and CT together are a powerful diagnostic tool (1) (2) 
(3), but imperfect image quality resulting from noise, spatial resolution, PVE and other factors 
allows false positive and false negative diagnoses to be made by observers despite experience 
and training.  PVE causes PET images to under report SUV in any sized region of interest (4).  
Corrections for PVE should allow for improved diagnostic performance (4). 
The correction scheme comprised several steps.  The observer drew a region of interest 
(ROI) around the lesion using the CT dataset.  The ROI was blurred with the point spread 
function (PSF) of the PET scanner then re-sampled to the PET voxel size.  The magnitude of the 
ROI-based PVE was used as a scaling factor to correct the lesion’s tumor-to-background ratio 
(TBR), which was used as a surrogate for SUV in the PET images of the phantom.  The 
correction scheme was characterized in terms of the assumptions that it made, such as lesion 
size, local PSF, and lesion positioning relative to the PET voxel grid.  Simulated PET data were 
used to evaluate the correction scheme.   
An observer study was conducted to obtain data to determine the effect of the correction 
scheme on lesion classification.  Observers were asked to rate PET/CT phantom images 
according to the likelihood of malignancy of a lesion visible in the image, both with and without 
PVE correction.  Ratings data were evaluated in terms of sensitivity, specificity and accuracy, as 
well with receiver operating characteristic (ROC) curve analysis.  Lastly, diagnostic performance 
of observers was evaluated as a function of acquisition mode and reconstruction algorithm, using 
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PET data alone, PET/CT data, and PET/CT data with correction of PVE.  Ratings used for this 
evaluation were acquired during the observer study. 
The evaluation of the correction scheme focused on its use for classification of single 
pulmonary nodules.  Simulations showed that the PVE correction accuracy depended strongly on 
the choice of lesion ROI, especially for small lesions.  However, for the range of ROI boundary 
errors examined, the corrected value was always more accurate than the uncorrected value.  Less 
error was observed for ROI boundaries that were too large than for boundaries that were too 
small.  When the assumed ROI boundary closely matched the true lesion size, the correction 
scheme produced an accurate corrected SUV value.  The correction scheme did not strongly 
depend on the accuracy of the assumed PSF. 
The observer study concluded malignant lesion classification performance improved with 
correction for PVE.  Using the correction scheme improved the observers’ ability to classify 
malignant lesions correctly.  This came at the cost of slightly reducing the observers’ ability to 
classify benign lesions correctly.  Corrected SUV values were more accurate compared to the 
true value than uncorrected SUV values 97% of the time. 
Also, this study found that PVE correction had more impact on classification performance 
than the choice of acquisition mode and reconstruction algorithm.  The observer study showed 
that for classification based on PET data alone, 3D OSEM images provided the best 
classification performance in terms of sensitivity, specificity, and area-under-the-ROC-curve 
values.  However, when PET data was evaluated with its correlated CT, the selection of 
acquisition mode and reconstruction algorithm did not significantly alter classification 
performance, either with or without PVE correction. 
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1.1 OVERVIEW OF THESIS 
This project, as summarized above, is described in the following chapters of the thesis.  
Chapter 2 discusses the goal, aims, hypotheses, and tasks of this work.  Chapter 3 reviews 
PET/CT imaging and ROC analysis, and discusses why an observer study was used in this thesis.  
Chapter 4 describes the research methods, including image acquisition and processing, how the 
correction scheme works, and how the implementation of the observer study.  Chapter 5 presents 
the results from the correction scheme characterization, the observer study, and the assessment of 
the correction scheme’s impact on lesion classification.  Chapter 6 summarizes the results and 
describes the conclusions drawn from the research.  
4 
 
CHAPTER 2:   
HYPOTHESES AND MOTIVATIONS 
2.1 PURPOSE 
The purpose of this study was to show that an SUV correction scheme, based on a model of 
PVE, can improve the accuracy of classification of single pulmonary nodules in PET/CT images. 
2.2 RESEARCH GOALS 
This work had three primary goals. 
1. To show that a model of voxelization, lesion size, and lesion location relative to the voxel 
grid can provide case-by-case correction of PVE in PET images. 
2. To evaluate the effect of the correction scheme on the accuracy of classification of single 
pulmonary nodules. 
3. To assess the influence of acquisition mode and reconstruction algorithm on the 
performance of the correction scheme. 
2.3 HYPOTHESES 
Two hypotheses guided this work.  This work sought to show that an SUV correction scheme 
will improve classification of single pulmonary nodules, by showing that PET images corrected 
for the effects of PVE yield more accurate classification than uncorrected PET data.  Acquisition 
mode and reconstruction algorithm were expected to affect the classification accuracy.  
2.3.1  Hypothesis 1 
The SUV correction scheme, for any choice of acquisition mode or reconstruction algorithm, 
will improve the quality of observers’ classifications, as measured by an increased ROC area-
under-curve (Az), sensitivity, specificity, and accuracy. 
An experienced observer should know that PET images misreport SUVs, especially for 
smaller lesions.  However, experience is likely insufficient to allow the observers to correctly 
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estimate the true SUVs.  The SUV correction scheme, by providing a quantitative estimate of the 
magnitude of error in the reported SUV, will help the observer to decide if an equivocal lesion 
should instead be classified as a concern.    
2.3.2  Hypothesis 2 
The observer study will show that for PET data, PET/CT data, and PET/CT data corrected 
for PVE, that ordered subset expectation-maximization (OSEM) reconstruction in 3D mode 
outperforms OSEM in 2D mode or filtered back projection (FBP) in either 2D or 3D mode, in 
terms of detection and classification of single pulmonary nodules.   
OSEM reconstruction creates smoother, sharper images than FBP (5); studies have shown 
that OSEM outperforms FBP in terms of lesion detection (5) (6).  The quantitative accuracy of 
OSEM is similar to that of FBP when the lesion is in a region of low background (7).  However, 
because the OSEM reconstruction algorithm creates qualitatively better images than FBP, the 
OSEM reconstruction algorithm should outperform FBP in terms of malignant lesion detection 
and classification of single pulmonary nodules.  
A 2D acquisition mode is less sensitive than a 3D mode, although it also has fewer scattered 
events and random coincidences.  Because the 3D mode is more sensitive, it should be less noisy 
and able to detect smaller lesions; the 3D mode is quantitatively more accurate (8).  Therefore, 
3D mode should outperform 2D mode in terms of malignant lesion detection and classification of 
single pulmonary nodules. 
2.4 LIST OF AIMS 
This project was executed in three main aims.  Chapter 4 describes the materials and methods 
used to complete these tasks.  Chapter 5 presents the results. 
1. Develop the SUV correction scheme (for Hypothesis 1) 
1a. Implement the correction scheme algorithm in software 
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1b. Characterize the behavior of the correction scheme using simulation data 
2. Develop the materials and methods for the observer study (for both Hypothesis 1 and 
Hypothesis 2) 
2a. Acquire and process the PET/CT data of simulated solitary pulmonary nodules in an   
 anthropomorphic torso phantom 
2b. Develop the presentation and data collection software for the observer study 
3. Conduct the observer study (for both Hypothesis 1 and Hypothesis 2) 
3a. Recruit experienced observers 
3b. Obtain the observer performance data for classification of single pulmonary nodules 
 with and without the correction scheme, for the combinations of acquisition mode and 
 reconstruction algorithm studied in this project 
3c. Analyze the observer data with ROC analysis and in terms of sensitivity, specificity, 
and accuracy 
3d. Assess quantitative accuracy of the correction scheme, including the impact of 
acquisition mode and reconstruction algorithm 
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CHAPTER 3: 
REVIEW OF PET/CT IMAGING AND ROC ANALYSIS 
3.1 PET/CT IMAGING 
PET/CT is a popular diagnostic imaging method.  PET maps metabolic activity; CT shows 
anatomy and provides attenuation correction factors needed for PET imaging.  Using these two 
modalities in combination reportedly improves diagnostic accuracy (9).   
3.1.1  PET Imaging 
PET is functional imaging.  When the radiotracer fluorine-18 flourodeoxyglucose (F-18 
FDG), a glucose analogue, is injected into a patient, the PET image maps glucose uptake.  
Glucose uptake is proportional to metabolic activity.  Increased metabolic activity can imply a 
number of things, one of them being malignant growth.  PET imaging has consequently become 
a popular tool for oncology imaging.  The following paragraphs provide a synopsis of PET 
imaging, followed by a discussion of PVE in PET imaging.  Reference (10) and other texts 
provide more extensive discussion about PET imaging hardware and methods.  
PET images are emission images – that is, a PET image maps the origins of photons created 
within and emitted from the body.  The photons are created when the radiotracer emits a positron 
which annihilates with a nearby electron, creating two 511 keV annihilation photons that travel 
in opposite directions from one another.  If the PET scanner detects these two photons within a 
particular interval of time, called the coincidence window, it will record a line of response (LOR) 
that connects the points where the two photons were detected.  The collection of LOR data is 
referred to as the projection data. 
When acquiring PET data, two types of spurious events can occur.  One type is when one or 
both of the annihilation photons can undergo Compton scattering before reaching a detector.  A 
scattered photon no longer travels in the opposite direction from the other annihilation photon, 
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and thus the recorded LOR will not intercept the position where the annihilation event actually 
occurred.  Another spurious event that can occur is called a random event.  This occurs when two 
photons that did not originate from the same annihilation event are detected within the PET 
scanner’s coincidence window.  The machine will erroneously record a LOR for these events. 
PET spatial image resolution is poor; a PET scanner’s point spread function (PSF) has a full 
width at half maximum (FWHM) usually around 6.5 mm or greater.  Because of poor spatial 
resolution, PET images typically have large voxels (relative to CT voxels), which cuts down on 
the number of voxels in an image and increases the speed of image reconstruction.   
Photons are attenuated within the patient.  The attenuation along each possible path the 
photons can take can be determined; for instance, the attenuation map of an object can be 
obtained from a CT scan.  Attenuation correction compensates for loss of signal in the PET 
image.  Attenuation has the largest effect on the central regions of the patient. Thus, attenuation 
correction makes lesions that are more central in the patient easier to find.  The combination of 
the annihilation photon data and the CT scan (for attenuation correction) is used to create the 
final PET image. 
Pet scanners acquire data in either 2D mode or 3D mode; some scanners are configured to 
utilize one mode exclusively, while other scanners are capable of using either acquisition mode.  
When acquiring data in 2D mode, the PET scanner places septa between the detector rings.  
These septa block photons that are travelling longitudinally (head-to-toe direction).  While this 
decreases the sensitivity of the machine, fewer random and scatter events are recorded with the 
septa in place.  In 3D mode, the PET scanner retracts these septa.  With the septa retracted, the 
PET scanner can detect more photons travelling longitudinally than when the septa are not 
retracted.  This increases the sensitivity of the machine at the expense of more recorded random 
and scatter events. 
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Once acquired, PET data can be reconstructed in a number of ways; two common methods 
are FBP and OSEM.  For FBP, the projection data are filtered with a ramp filter to correct for the 
blurring caused by backprojection.  The projection data are then added back, or back-projected, 
into a tomographic image (10).  OSEM is an iterative approach to image reconstruction (10).  For 
OSEM, an initial activity distribution within the patient is assumed.  Projection data are 
calculated using the assumed activity distribution and compared to actual projection data.  The 
assumed activity distribution is adjusted based on this comparison.  This process is repeated until 
actual projection data and assumed projection data match, within a certain tolerance. 
PET data are often displayed in units of SUV.  SUV is ratio of the radiotracer density in a 
given region to the total body mean uptake in the patient, so 
(1)  SUV ൌ  
Rୟୢ୧୭୲୰ୟୡୣ୰ ୳୮୲ୟ୩ୣ ሾMB౧
ౣL
ሿ
Aୢ୫୧୬୧ୱ୲ୣ୰ୣୢ ୟୡ୲୧୴୧୲୷ ሾMB୯ሿ/ሺଵ଴଴଴כPୟ୲୧ୣ୬୲ ୵ୣ୧୥୦୲ ሾ୩୥ሿሻ
 
If the density of the patient is assumed to be the same as water (ρ = 1 g/mL), total body SUV is 
equal to one.  SUV is higher for metabolically active tissues, such as the heart, brain, or tumors. 
The combination of inherent system resolution and image voxelation, otherwise known as 
PVE, causes a misreporting of SUV in any region of interest, which may reduce a PET image’s 
sensitivity for finding malignancies. 
3.1.2  Partial Volume Effect 
PVE occurs from voxelation of PET images and from finite spatial resolution inherent in a 
PET scanner.  Unblurred images of two lesions are illustrated in the left column of Figure 1.  
These images have voxels that are very small relative to the size of the lesions they depict.  In the 
top row, the lesion is centered on a voxel corner while the lesion in the bottom row is centered on 
the center of a voxel.  The finite spatial resolution causes an apparent spillover of activity from 
one region into another (4), as seen in the middle column of Figure 1, where the lesions appear 
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blurred.  Two sources of error arise from voxelation.  One is that voxelation averages data over a 
volume, causing a loss of spatial information, as seen in the right column of Figure 1, where the 
blurred images of the lesions appear blocky.  The other source of error is that an object will look 
different depending on its position relative to the center of a voxel, as seen between the top and 
bottom images in the right column in Figure 1.  In the top right image in Figure 1, the lesion is 
positioned over a voxel corner, resulting in the highest value of the image being shared between 
the four voxels that share the center of the lesion.  In the bottom right image in Figure 1, the 
highest value of the image is seen in only one voxel, because the lesion is centered inside a 
voxel.   
 
 
 
Figure 1:  The effects of resolution and voxelation.  Top row shows an object centered on the 
corner of a PET voxel and the bottom row shows an object centered on the center of a 
PET voxel.  The left column shows the object unblurred and unvoxelated.  The middle 
column shows the object blurred.  The right column shows the effects of blurring and 
voxelation.  The blurring function was a Gaussian with a FWHM equal to the diameter of 
the object. 
There are a number of different methods to correct for PVE.  Images can be corrected on a 
regional level (e.g. the average of an aggregate of pixels is corrected) or on a pixel-by-pixel 
basis.  The values of individual pixels in PET images are highly variable and noise levels vary 
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between acquisition mode, reconstruction algorithm, patient size, and scan time length (4) (11) 
so pixel-by-pixel corrections are most useful for images with low noise (4).  Three methods that 
correct for PVE on a regional level are the deconvolution method (12), the recovery coefficient 
method (13), and the geometric transfer matrix method (14).  The deconvolution method 
iteratively deconvolves the region of interest in the PET image with the local PSF; it does not 
require anatomical data for delineation of the tumor boundary.  The deconvolution method 
requires knowing the local spatial resolution to within 1 mm FWHM across the field of view 
(FOV) (8).  Deconvolution is only appropriate for use with tumors with diameters greater than 
1.5 times the local PSF FWHM (12).  This method greatly amplifies noise.  However, PET 
images corrected for PVE by deconvolution were more accurate than non-PVE corrected PET 
images even for sub-centimeter tumors (12).   
The recovery coefficient method requires correlated anatomical data to find the actual tumor 
boundary.  This method assumes homogenous uptake of FDG within the tumor.  A recovery 
coefficient is found using the tumor region of interest (ROI).  The recovery coefficient is 
multiplied by either the mean or maximum SUV within the ROI to give a PVE corrected value.  
There are several methods for creating a recovery coefficient.  Assuming a spherical tumor, 
simple simulations of PVE can be done beforehand of spherical lesions, varying lesion diameter 
and scanner resolution to create a look up table.  Once a tumor’s volume has been determined, 
the proper recovery coefficient is obtained from the look-up table using a spherical volume equal 
to that of the tumor volume.  This method has been commonly used in PET tumor imaging (4) 
and can increase PET’s ability to find malignancies (13).  Another way of finding the recovery 
coefficient is to do a simulation on-the-fly using a lesion ROI.  This is more accurate for lesions 
that are not spherically shaped or for tumors with necrosis; it is identical to the look-up table 
method if the tumor and its correlated ROI are both spherical, and if the tumor is positioned in 
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relation to the voxel grid in the same way as the simulated lesion that was used to make the 
correction factor.  For lesions only somewhat larger than the voxel size of the PET image, 
positioning with respect to the voxel grid may have a large impact on the accuracy of the 
recovery coefficient.  Simulation based on the lesion ROI is the method used in this study. 
The geometric transfer matrix method is an extension of the recovery coefficient method.  
Instead of assuming a single surrounding structure, as the recovery coefficient method does, the 
geometric transfer matrix method assumes that there are multiple different structures surrounding 
the ROI (4).  Correlated anatomical data is required to delineate each surrounding structure.  This 
method was not applicable for this study because lung is the only structure surrounding the 
simulated lesions in this study. 
3.1.3 CT Imaging 
CT is useful for anatomical imaging and can be used both for diagnosis and for attenuation 
correction of PET data.  CT images are computed from transmission images – x-rays enter a 
patient from one side and those that emerge from the other side are detected.  Data in a CT image 
thus represents x-ray attenuation.  A single transmission measurement through an object made by 
a single detector is called a ray.  Each set of rays that passes through an object at a given 
orientation of the x-ray source and detector is a projection.  To create a CT image of a single 
slice of an object, many rays must be measured at many projection angles.  Once these 
measurements are made, projection data are filtered to correct the blurring caused by the image 
reconstruction process. The filtered projection data are then added back, or back-projected, into a 
tomographic image.  CT image spatial resolution is better relative to PET resolution. CT voxels 
are usually around 1 mm on a side, which are small compared to PET image voxels.  The 
fundamentals of CT imaging are discussed in texts such as reference (10). 
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3.2 ASSESSING DIAGNOSTIC PERFORMANCE WITH OBSERVER 
STUDIES 
While many studies have characterized PET and PET/CT scanners in terms of resolution, 
noise, and other characteristics (15) (16), the ultimate arbiter is diagnostic performance (17).  
Diagnostic performance is important because it assesses quality of decisions based on a system’s 
images.  Ultimately, an observer must make diagnoses based on a system’s images.  The quality 
of an observer’s diagnoses is evaluated to give the diagnostic performance of a system. 
3.2.1  Populations and Diagnostic Tests 
A trait that may indicate disease can be shared between both healthy and diseased 
populations.  A diagnostic test may be designed to measure the extent of this trait.  In Figure 2, 
the distribution of healthy (left Gaussian curve) and diseased (right Gaussian curve) individuals 
with respect to the extent of the trait measured by a generic diagnostic test is shown.  Notice that 
the test does not perfectly discriminate between healthy and diseased individuals – the two 
Gaussian curves overlap.  Some healthy individuals show a higher amount of measured trait than 
some diseased individuals, for this particular example. 
3.2.2  Metrics for Diagnostic Performance 
Diagnostic performance can be assessed by measuring sensitivity, specificity, accuracy, or a 
number of other metrics.  Sensitivity is the fraction of positive cases correctly identified as 
positive, specificity is the fraction of negative cases correctly identified as negative, and 
accuracy is the fraction of cases identified correctly, whether positive or negative (18).   
3.2.3  ROC Analysis 
Another method for assessing diagnostic performance of a test, person, or imaging system is 
ROC analysis.  The ROC curve shows the tradeoff between true positive fraction (TPF or 
sensitivity) and false positive fraction (FPF) (18).  The relationship of the populations to TPF and 
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FPF, as well as true negative fraction (TNF or sensitivity) and false negative fraction (FNF) are 
illustrated in Figure 2.  FPF is the fraction of negative cases incorrectly identified as positive;  
 
Figure 2:  Distribution of healthy and diseased populations with respect to a test metric.  The 
vertical purple line is the decision boundary above which cases are labeled positive.  
Displayed are true positives (blue hatch), true negatives (solid green), false positives 
(solid yellow), and false negatives (red hatch). 
 
FPF is one minus the specificity.  The ROC curve illustrates the impact of decision threshold 
placement.  Each decision threshold corresponds to the value chosen to (arbitrarily) demarcate 
the states of health and disease using the test’s measurements (Figure 2). An example of a 
decision threshold would be a particular SUV above which a test would label a lesion malignant.  
For the comparison of diagnostic tests, persons, or imaging systems, the ROC curve illustrates 
relative performance at specific decision thresholds. 
Sensitivity, specificity, and accuracy only give diagnostic performance at a single decision 
threshold.  However, an ROC curve maps TPF and FPF as a function of decision threshold, 
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showing the relative impact of decision threshold placement.  Combining the knowledge of the 
tradeoffs between TPF and FPF at a given decision threshold and the knowledge of the relative 
costs (time, money, scheduling, etc.) of true and false positives can help with the selection of an 
optimal decision threshold for a given test (17) (19).  Optimal placement of the decision 
threshold will maximize the number of true positives at an acceptable number of false positive 
mistakes. 
The typical ROC curve plots TPF versus FPF as a function of decision threshold.  To 
populate the points on this curve, diagnostic decisions are rated on a confidence scale.  Ratings 
are used instead of a binary yes/no system to assess the performance of the system at different 
decision thresholds.  Each rating level corresponds to a different decision threshold.  At each 
threshold, positive images with measurements above the decision threshold are true positive 
results while negative images with measurements above the threshold are false positive results, 
as seen in Figure 2.  The relationship between decision threshold (vertical purple line), the 
underlying populations of health (Gaussian distribution on the left) and disease (Gaussian 
distribution on the right), and the distribution of true positives (blue hatch), false positives (solid 
yellow), true negatives (solid green) and false negatives (red hatch) for a generic test is shown in 
Figure 2.  The x-axis represents the extent of the measured trait and the y-axis represents the 
frequency of occurrence. 
When attempting to fit a curve to the ROC rating data, a binormal population distribution 
may be assumed, with each normal distribution describing either the healthy or diseased 
populations (19).  The independent variable is a diagnostic test result that correlates to the 
disease in question.  The populations relate to the ROC curve through the parameters 
(2)  a = (distance peak-to-peak)/σ healthy population histogram  
and 
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(3)  b = σ diseased population histogram/σ healthy population histogram. 
The ROC curve, as a function of a, b, and FPF, is 
(4)  TPF ൌ  ଵ
ଶ
ሺ1 ൅ erfሺ ଵ
√ଶ
ሺࢇ ൅  √2 ࢈ כ  erf ିଵሺ2 כ  FPF െ 1ሻሻሻ 
An ideal test would maximize a and minimize b, which would maximize TPF for all points 
on the ROC curve, as can be derived from equation (4).  This would correspond to an increased 
Az, the integral of the ROC curve, which is also called the area-under-curve.  Maximizing a and 
minimizing b increases the separation of the distributions of the diseased and healthy populations 
with respect to the range of possible test results, and thus makes determining a diseased case 
from a healthy case easier.  In the top left plot in Figure 3, the healthy and diseased populations 
are well separated and thus the fitted ROC curve has an a value that is large relative to its b 
value.  Its plotted ROC curve, shown in the bottom right plot (dot-dashed line) of Figure 3, has a 
very high TPF for all decision thresholds and thus has a high Az.  A poor test cannot differentiate 
the populations from each other (top right plot of Figure 3), so it will have a fitted ROC curve 
with a small a, a large b, and a correspondingly low Az (bottom right plot of Figure 3, dashed 
line).  The bottom left plot of Figure 3 shows a typical situation where the distributions overlap.  
The fitted ROC curve will have moderate values for a and b, resulting in the typical ROC curve 
shown in the bottom right plot of Figure 3 (solid line).  The distributions in Figure 3 are 
normalized.  However, ROC analysis does not require normalized distributions. 
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Figure 3:  Distributions of healthy and diseased populations for good (top left), poor (top right), 
and typical (bottom left) tests.  The corresponding ROC curves are plotted at bottom 
right.  For the poor test, the healthy and diseased populations overlap completely. 
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CHAPTER 4:   
METHODS AND MATERIALS 
4.1 AIM 1:  DEVELOP THE SUV CORRECTION SCHEME 
In this section, the implementation of the recovery coefficient method of correcting for PVE 
is described.  The recovery coefficient method was explained in Section 3.1.2; our 
implementation uses observer-drawn ROIs for case-by-case correction (4). 
4.1.1  Implementation of the Correction Scheme Algorithm in Software 
The correction scheme proceeded in several steps to determine the correction factor for a 
lesion.  First, an ROI was drawn on the correlated anatomical CT data that matched the lesion 
boundary; the ROI was drawn using the CT data because of its higher resolution relative to the 
PET data.  The PET ROI was created by copying the CT ROI to the corresponding PET image.  
Because PET voxel size did not match CT voxel size, a new PET boundary was made to 
determine the mean PET value.  Voxels were assigned to the PET ROI if at least 50% of the PET 
voxel was overlapped by voxels from the CT drawn ROI.  The mean PET value within the PET 
ROI was calculated.  A simulated lesion image, defined by the CT drawn boundary, was created 
at the CT voxel size, given a uniform SUV, and blurred by the assumed PSF of the PET data.  
Blurring was done to mimic the effects of the imaging system.  To blur the image of the lesion, 
the simulated lesion was convolved with the PSF.  The PSF was a Gaussian distribution with 
dimensions of 6.5 x 6.5 x 6.0 mm3 FWHM (in lateral, anterior-posterior, and craniocaudal 
directions, respectively), derived from results from measured PSF data for the same model 
PET/CT scanner used in this work (20).  This blurred image was re-sampled to the PET voxel 
size to mimic the effect of voxelation.  The known SUV of the simulated lesion was divided by 
the mean of the blurred and pixelated simulated lesion within the PET ROI to obtain the 
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correction factor.  The measured mean PET value was then multiplied by the correction factor to 
create the corrected mean. 
4.1.2  Evaluation of the Correction Scheme with Simulation Data 
Simulated data were created both to evaluate the behavior of the SUV correction scheme 
used in this investigation and to help guide how corrected values and bounds should be created 
and displayed to the observers in the observer study.   
To evaluate the correction scheme, the output of the scheme was investigated for a variety of 
adjustable scheme parameters.  These parameters included lesion radius, scanner PSFs in the 
transverse and axial directions, and lesion placement relative to the voxel grid.  For each 
parameter set, a simulated lesion image was created at the specified lesion size and positioned on 
a 0.25 mm x 0.25 mm x 0.25 mm voxel grid.  The boundary of the lesion was drawn using CT 
sized voxels (0.98 mm x 0.98 mm x 3.27 mm).  The lesion was blurred by the specified PSF.  
Finally, the lesion image was resampled to the larger PET voxel size (4.69 mm x 4.69 mm x 3.27 
mm).  This simulated lesion image was then used as input to the correction scheme. 
The effects of several other variables were also investigated.  One was the correction factor 
simulation PSF, which may not match the actual scanner PSF.  Another variable was error in the 
CT drawn ROI.  A new ROI, which slightly mismatched the ROI of the simulated PET lesion, 
was drawn for the correction factor simulation, which provided a means to evaluate the effect of 
boundary accuracy. 
4.2 AIM 2:  DEVELOP THE MATERIALS AND METHODS FOR THE 
OBSERVER STUDY 
The second task of this study was to acquire and process PET/CT data for the observer study.  
Phantom images were used, instead of human images.  With the use of a phantom, the exact 
values of radiotracer uptake and lesion size were known and controllable.  Phantom images were 
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acquired for various lesion sizes and lesion radiotracer activity concentrations, as well as for two 
acquisition modes and two reconstruction algorithms. 
4.2.1  The GE Discovery ST PET/CT Scanner 
The PET/CT scanner used in this study was a GE Medical Systems Discovery ST PET/CT 
scanner.  System specifications are summarized in Table 1.  Retractable septa exist between the 
rings of detectors to allow acquisitions in either 2D or 3D mode.  The scanner provides several 
reconstruction algorithms, including the OSEM and FBP algorithms used in this project.  The 
scanner acquires the image data sequentially, acquiring helical CT data first then PET data.  The 
CT data is used for both attenuation correction of the PET data during tomographic 
reconstruction and for co-registered display of anatomical images with the PET images.  The 
spatial resolution of the PET imaging component, as measured for this model PET/CT scanner 
by Bettinard et. al. (20), is summarized in Table 2. 
Table 1:  GE Discovery ST manufacturer’s specifications (15) 
Attribute Value 
Detector material Bismuth Germanate 
Energy window (keV) 375-650 
Crystal dimensions (mm3) 6.3 x 6.3 x 30 
Number of photomultiplier tubes 280 
Coincidence window (ns) 11.7 
Number of detector rings 24 
Number of detectors per ring 420 
Number of image planes 47 
Detector ring diameter (cm) 88.6 
Transverse FOV (cm) 70 (PET), 55 (CT) 
Axial FOV (cm) 15.7 
 
Table 2:  GE Discovery ST resolution at different positions within the scanner (20) 
Position/acquisition plane FWHM (mm) (2D mode) FWHM (mm) (3D mode) 
1 cm radius/transverse 6.28 6.29 
1 cm radius/axial 4.56 5.68 
10 cm radius/transverse radial 6.94 7.01 
10 cm radius/transverse tangential 6.82 6.64 
10 cm radius/transverse axial 6.11 6.05 
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4.2.2  Phantom 
The phantom comprised several components (Figure 4).  The anthropomorphic torso 
phantom and the simulated lesions were the components imaged.  The scatter phantom was used 
to mimic out of field scatter.   
 
Figure 4:  Pictured from left to right:  The anthropomorphic torso phantom, a sample of micro 
hollow spheres used to simulate lesions, and the scatter phantom. 
 
The torso phantom was the Data Spectrum Anthropomorphic Torso Phantom™ (Model 
ECT/TOR/P)1 with the Cardiac Insert™ (Model ECT/CAR/I)1.  The torso phantom simulates 
patients of average size (38 cm x 26 cm).  The torso phantom includes two lung compartments 
filled with Styrofoam® beads.  These compartments, when filled with water, simulate lung tissue 
with a density of ~0.3 g/mL.  The other structures modeled in the torso phantom are the spine, 
which is a Teflon® cylinder, and the liver.  The heart is simulated with two chambers:  one for the 
myocardium and the other for the left ventricle: In nuclear medicine imaging, only the left 
ventricle is typically visualized, so it is the only chamber that is modeled in the phantom.   
Clinically, radiotracer is not confined to the portion of the patient within the imaging FOV.  
To ensure that the acquired images reasonably represented clinical conditions for scatter, the 
NEMA PET Scatter Phantom™ (Model PET/NEMA-SCT/P)1 was used.  The scatter phantom 
was positioned distal to the anthropomorphic torso phantom and outside the imaging FOV.  The 
                                                 
1 Data Spectrum Corporation, 437 Dimmocks Mill Rd, Suite 17, Hillsborough NC 27278-2300 
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scatter phantom is a right circular polyethylene cylinder 70 cm in length and 20.3 cm in 
diameter.  The scatter phantom has a fillable line source insert.   
Fillable hollow acrylic spheres were used to simulate lesions.  The spheres were from the 
Hollow Sphere Set (6)™ (Model ECT/HS/SET6)1 and the Micro Hollow Sphere Set (4)™ 
(Model ECT/MI-HS/SET4)1.   Images acquired of radioactivity filled spheres used sphere sizes 
of 0.125, 0.25, 0.5, 1.0, and 2.0 mL (fillable volumes).  Images acquired of non-radioactive 
spheres used sphere sizes of 0.031, 0.063, 0.125, 0.25, 0.5, 1.0, and 2.0 mL (fillable volumes).  
Radioactivity-filled “hot” spheres represented lesions with PET radiotracer uptake, or PET active 
lesions, while “cold” spheres represented lesions with no PET radiotracer uptake.  These “cold” 
lesions had the same uptake as their surrounding medium, the simulated lung. 
4.2.3  Phantom Preparation 
For this study, images were displayed in units of tissue to background ratio (TBR) instead of 
SUV.  TBR is unitless:  It is the radiotracer concentration in a given compartment of the phantom 
divided by the radiotracer concentration in the background portion of the phantom.  The 
background portion of the phantom was meant to simulate the total body mean; total body mean 
SUV is one, assuming a patient density equal to that of water.  The background portion of the 
phantom surrounded the lungs, heart, liver, and spine.  Because each image was normalized to 
the activity concentration within the background portion of the phantom, the values for SUV and 
TBR were thus equivalent in magnitude.  The actual TBRs used in the different compartments of 
the phantom were zero for the heart ventricle and lungs, 8.94 - 10.6 for the myocardium, 2.52 - 
2.79 for the liver, 1 for the background, 0.968 - 1.14 for the scatter phantom, and 0 to 7.56 for 
the simulated lesions.  Healthy lungs in patients normally have an SUV of 0.6 to 0.8.  However, 
placing radioactivity in the lungs would have complicated the image acquisition and greatly 
increased the likelihood of contamination of personnel and equipment.  The total activity injected 
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into the phantom, at time of assay, ranged from 5.16 mCi to 7.44 mCi for the various acquisition 
sessions.   
After filling, the phantom was positioned on the PET/CT scanner table.  The scatter phantom 
was placed according to NEMA recommendations for evaluating image quality (21).  For 
acquisitions that included a simulated lesion, a single sphere was placed in one of the lung 
chambers.  Multiple acquisitions with various lesion sizes were made during each session by 
replacing the spheres and repositioning the phantom.  For each acquisition session, a different 
actual lesion TBR was used. 
4.2.4  Acquisition Protocols and Reconstruction Methods 
Following typical clinical protocols on the Discovery ST scanner used for this project, 4 
minutes per bed position were used for 2D acquisitions and 3 minutes per bed position were used 
for 3D acquisitions.  The 2D acquisitions were imaged prior to 3D acquisitions so that a 
clinically realistic count rate would be seen for the 2D image sets and then the activity could 
decay sufficiently to provide a reasonable count rate for the subsequent 3D acquisitions.  The 2D 
sets were imaged at 1-2.5 hours after assay while the 3D sets were acquired at 2.5-4 hours after 
assay.  Once a sinogram had been acquired, it was reconstructed both with FBP and with OSEM.  
The 3D OSEM data sets were reconstructed at 256x256 pixels per slice, but were re-binned for 
the observer study to 128x128 pixels per slice to match the other data sets.  Figure 5 illustrates 
two fused PET/CT images acquired for this study.  Table 3 lists the reconstruction parameters 
used in this study. 
4.2.5  Image Processing 
The PET images were manually rebinned and cropped to match the CT pixel size and FOV.  
The CT images were shifted by half of a PET pixel in both the lateral and anterior-posterior  
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similar to the histogram of the CT values in the phantom lung.  The modified ROI, along with 
the original CT values adjacent to the ROI, was then convolved with a Gaussian distribution with 
a 2 mm FWHM to blend the modified ROI into the original CT data.   
The PET data was stored with values in units of activity concentration, Bq/mL.  Although 
OSEM applies a non-negativity constraint during reconstruction, FBP does not.  The nature of 
FBP can create negative values which are spurious, as there is no such thing as a negative 
activity concentration.  Thus all negative values in the PET data were replaced with a value of 
zero. 
To convert the PET images from Bq/mL to TBR, several steps were required.  First, the 
average activity concentration of the PET data set, At, was found by summing the total activity in 
the PET data set and dividing that value by the total fillable internal volume of the torso phantom 
(11,050 mL).  Only image slices containing the torso phantom were used to find this average.  
The entire data set was then normalized to this average value.  To finally convert the pixel data 
to TBR, the images were scaled to produce an activity concentration of one inside the 
background portion of the torso phantom.  The background portion of the phantom was very 
large compared to both the scanner resolution and the PET image voxel size and thus would not 
be greatly affected by PVE, so the scaling could be based on the background portion of the 
phantom.  The scaling factor used to accomplish this was derived assuming that the ratio of the 
measured activity concentration in the background portion of the phantom, Ab, to At in the PET 
image would be equal to the ratio of the actual background Ab, true to total At, true activities 
injected into the phantom.  That is,  
(5)    Aౘ
A౪
ൌ
Aౘ,౪౨౫౛
A౪,౪౨౫౛
. 
Thus, for each compartment of the phantom, the scaling factor was 
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(6)  A୧ כ
A౪,౪౨౫౛
A౪כAౘ,౪౨౫౛
ൌ TBR୧,  
where i represents the compartment, e.g., liver or myocardium. 
4.2.6  Image Display Software 
The image display software (Figure 6) that was used to present images to observers was 
written in house in IDL2 and had a number of features.  The PET and CT data and ROIs could be  
 
Figure 6:  Screen shot of the image presentation software. The user can view and zoom PET, CT 
and fused PET/CT images, can alter the color table and display windows, and enter rating 
responses. 
 
displayed individually or fused for simultaneous viewing.  Only transverse slices were displayed.  
Observers were given the option to draw a single ROI per slice.  A number of ROI manipulation 
options were available – the user was allowed to draw an ROI using the mouse, erase an ROI 
using the mouse, erase the ROI completely or per slice, set the ROI based on CT threshold 
values, or grow the ROI from a selected point based on CT values.  Observers were allowed to 
                                                 
2 ITT Corporation, 4990 Pearl East Circle, Boulder, CO 80301 
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change the window and level of both the PET and CT data, to zoom in and out, to move between 
slices in the data set, to view PET TBRs either point-by-point or within an ROI, and to review 
PET statistics within an ROI.  
4.2.7  Final Image Data Sets 
There were 104 image sets total, of which 78 images had PET active lesions (lesions that 
contained any amount of activity) while 26 images had no lesion or a lesion with no activity.  
Thirty-eight images had malignant lesions (lesions that had an activity concentration at least 2.5 
times that of the background) while 66 had no lesion or a benign lesion.  Of the 78 PET active 
lesions, 40 were not malignant. 
4.3 AIM 3: CONDUCT THE OBSERVER STUDY 
The third task of this project was to conduct the observer study with appropriate experienced 
observers (radiation oncologists, nuclear medicine physicians and medical physicists) using the 
software described in Section 4.2.6 to sequentially display the processed PET/CT data, to record 
image ratings (for the existence of a PET active lesion and for malignant lesion classification), 
and both to obtain the ROIs needed for the SUV correction scheme and to present the corrected 
data to the observer.  The data acquired from the observer study were used to evaluate the 
hypotheses of this work. 
4.3.1  Lesion Detection and Malignant Lesion Classification Studies 
Observer performance was assessed for two tasks.  The lesion detection study (LDS) gauged 
observers’ abilities to identify the presence of a PET active lesion in a PET image or in a 
PET/CT image.  The malignant lesion classification study (MLCS) judged observers’ abilities to 
classify a lesion as benign or malignant based on TBR values. 
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4.3.2  Image Rating 
For each image set, the PET image alone was first displayed to the observer.  The observer 
rated the PET image for the existence of a PET active lesion; this rating was part of the LDS.  
The rating was based on a five point scale, one meaning “a PET active lesion definitely does not 
exist” and five meaning “a PET active lesion definitely exists”.  Image sets with no lesions or 
lesions with no PET activity were considered to be negative as PET active lesions.  The PET 
image was also rated for the existence of a malignant lesion for MLCS.  The MLCS rating was 
also based on a five point scale, one meaning “the lesion is definitely not malignant” and five 
meaning “the lesion is definitely malignant”.  In the case of non-small cell lung cancer, lesions 
with SUV greater than 2.5 may be considered malignant (22).   
After rating the PET image alone, the correlated CT data was displayed with the PET data.  
The PET/CT data was rated for both the LDS and MLCS using the same scale as for the PET 
image alone.  Observers were instructed to use the CT data only for lesion localization; ratings 
for PET active lesions and malignancy were based on the PET data. 
The observer was then asked to draw ROIs on all slices of the PET/CT data for which the 
lesion was visible.  These ROIs were used as input to the correction scheme.  When drawing the 
ROI, the observer was instructed to exclude the acrylic shell of the simulated lesion; the shell did 
not include radioactivity, so it should not be included in the SUV correction scheme’s 
calculations (real lesions would not have a shell). 
For each case, the correction scheme calculation was repeated for dilated and eroded versions 
of the observer’s ROIs.  The ROIs were dilated or eroded on a slice by slice basis creating ROIs 
that were larger or smaller, respectively, by 1 mm in the radial direction.  This showed the 
observer how a change in ROI size altered the corrected TBRs.  A 1 mm change in boundary was 
selected because the CT pixel size was approximately 1 mm2.  These additional correction values 
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were displayed to the observers along with the value based on the original ROI.  The observer 
rated the data for malignancy using the corrected values; the LDS was not used here because the 
SUV correction scheme does not alter the detection of lesions. 
The process of rating the PET data, the PET/CT data, and then the corrected PET/CT data 
was repeated for all 104 image sets in this study.  The order of presentation of the PET/CT image 
sets was randomized for each observer.   
To populate the points for each ROC curve, the ratings were grouped at four different 
thresholds.  For the threshold with the highest FPF and TPF, all ratings between two and five 
were considered positive ratings while the lowest rating, one, was considered a negative rating.  
TPF and FPF were calculated using these considerations.  For the next threshold with a slightly 
lower FPF and TPF, all ratings between three and five were considered positive ratings while the 
two lowest ratings, one and two, were considered negative ratings.  This process was repeated 
similarly for the next two decision thresholds. 
4.3.3  Observer Performance Assessment 
The observers’ response data were categorized by acquisition mode (2D or 3D), 
reconstruction algorithm (FPB or OSEM), observer type (nuclear medicine physicians, radiation 
oncologists, medical physicists, numerical), and study type (LDS or MLCS).  The response data 
were then entered into ROCKIT 0.9B3.  ROCKIT was used to obtain a maximum-likelihood 
estimate of the parameters, a and b, for the conventional binormal model of the ROC curve and 
for the area under the curve Az, as well as the standard deviation for all of these values.  Az is one 
metric that can be used to compare different ROC curves. 
In addition to Az, the performance markers of sensitivity, specificity, and accuracy were used 
to judge the observer data.  Sensitivity is the number of true positives (TP) divided by the sum of 
                                                 
3 University of Chicago (webpage url:  http://www-adiology.uchicago.edu/krl/KRL_ROC/software_index6.htm) 
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the TP and false negatives (FN).  Specificity is the number of true negatives (TN) divided by the 
sum of the TN and the false positives (FP).  Accuracy is the sum of the TP and TN divided by 
the total number of all cases, or the sum of the TP, TN, FP, and FN.  To calculate these values 
for each observer, the two most positive responses and the three most negative responses from 
the ROC study were lumped together. When referring to statistical significances between pairs of 
values, “no significance” means that the values lie within each others’ 1-σ standard deviation, 
“marginal significance” means that the values overlap at the level of two standard deviations, 
and “significance” means that the values are further than two standard deviations apart.  
Equations (8) through (14) give the equations that determine the standard deviations (σ) for the 
sensitivity, specificity, and accuracy (23).   
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4.3.4  Assessing the Quantitative Accuracy of the Correction Scheme 
Once all observers were finished with the study, a numerical observer was used to further 
evaluate the efficacy of the SUV correction scheme, as part of the first hypothesis of this study.  
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The numerical observer was used to quantitatively evaluate the impact of the SUV correction 
scheme.  The numerical observer used the ROIs drawn by the experienced observers.  To 
evaluate each data set, the numerical observer computed an average TBR from all human 
observer drawn ROIs.  This was repeated for the eroded and dilated versions of the human 
observer drawn ROIs to evaluate the effect of a change in lesion boundary definition.  ROIs with 
a volume greater than 2.5 mL were not included in the average.  The largest spherical lesion used 
in this study was 2.0 mL in size so any ROI larger than 2.5 mL was created by an observer that 
was not careful in the use of the pixel growing method used to create the ROI.  Fortunately, this 
was a rare occurrence and only occurred with one set of data with a few of the observers where 
the largest lesion was placed close to the bottom corner of the simulated lung.  For these cases, 
the ROI grew outside of the lesion and into the background compartment of the phantom. 
The sensitivity, specificity, and accuracy of the numerical observer were calculated in the 
same manner as for the human observers.  The numerical observer used a fixed TBR threshold of 
2.5 to classify images as malignant.  For an average TBR of 2.5 or larger, the image was 
classified as malignant; for an average TBR less than 2.5, the image was classified as not 
malignant.  
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CHAPTER 5:   
RESULTS 
The layout of this chapter follows the order of the research problems enumerated in Chapter 
2.  The results of the scheme characterization are in Section 5.1, the impacts of the correction 
scheme are given in Section 5.2, and the effects of acquisition mode and reconstruction 
algorithm selection on lesion detection and classification in PET images, PET/CT images, and 
PET/CT images with PVE correction are given in Section 5.3. 
5.1 CHARACTERIZATION OF THE CORRECTION SCHEME 
 The SUV correction scheme was tested with simulation data.  This simulation data evaluated 
factors such as tumor size, positioning of the tumor with respect to the PET voxel matrix, 
mismatch of the PSF of the scanner to the PSF used by the correction scheme, mispositioning of 
ROI boundaries, and PET voxel size.  Figure 7 illustrates TBR recovery with and without PVE  
 
Figure 7:  Percent recovered mean TBR as a function of lesion radius using simulated data when 
the correction PSF matched the simulated scanner PSF, for lesions centered over the 
middle of a PET voxel (left) vs. centered over a PET voxel corner (right).  
 
correction as a function of lesion size, ROI size mismatch, and lesion location relative to the 
voxel grid.  The lesion is centered over a voxel in Figure 7 (left) and over a voxel corner in 
Figure 7 (right).  The results shown in Figure 7 used a PET voxel size of 4.69 mm x 4.69 mm x 
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3.27 mm and a CT voxel size of 0.98 mm x 0.98 mm x 3.27 mm.  The correction scheme’s PSF 
was a Gaussian function with an axial width of 6.5 mm FWHM and a longitudinal width of 6.0 
mm FWHM. Figure 7 plots the results for the correct ROI size and for a ±1 mm mismatch in 
ROI size.  The ±1 mm mismatch shows the bounds on the corrected TBR given such an error in 
ROI size.   
Error in ROI size had a noticeable effect on the corrected TBRs for small lesions, especially 
if the ROI was too small compared to the lesion.  Corrected TBRs for the larger lesions were less 
affected by ROI mismatch.  The simulation results in Figure 7 show that the simulated PSF used 
for the correction factor simulation produced 99-112% TBR recovery when the lesion was 
centered over a voxel and 101-157% TBR recovery when the lesion was centered on a voxel 
corner.   
In Fig. 7, the correction scheme PSF exactly matched the simulated scanner PSF.  Figure 8 
shows the effect of mismatch between the correction scheme PSF and the assumed scanner PSF 
as a function of ROI size.  The simulation for Figure 8 used a PET voxel size of 4.69 mm x 4.69 
mm x 3.27 mm and a CT voxel size of 0.98 mm x 0.98 mm x 3.27 mm. The simulated lesions 
were located over the center of a PET voxel.  For the Discovery ST scanner used to acquire the 
PET/CT images of the torso phantom, the actual PSF varied not only with position in the 
scanner, but also with the acquisition mode used to create each image (Table 2).  The PSFs for 
the acquisition modes were similar except in the axial direction at the center of the field of view 
(FOV), where 3D mode was poorer than 2D mode.  The resolution worsened for both modes 
when moving away from the center of the FOV.  Throughout this work, a PSF of 6.5 mm 
FWHM in the axial direction and 6.0 mm FWHM in the longitudinal direction was used in the 
correction scheme at all times. 
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Figure 8:  Percent recovered mean TBR as a function of lesion radius using simulated data when 
the correction PSF did not match the scanner’s local PSF, for lesions located over the 
center of a PET voxel.  Scanner PSF varied with position in the FOV, as summarized in 
Table 2. 
 
The simulation results in Fig. 8 show that the mismatched PSF of the correction scheme 
produced 96-107% TBR recovery for 2D mode and 96-109% TBR recovery for 3D mode when 
the lesion was 10 cm from the center of the FOV and the ROI matched the actual lesion 
boundary.  For lesions 1 cm from the center of the FOV, the correction scheme over-reported 
TBR by 8-21% for 2D mode and 2-16% for 3D mode.  Thus, PSF mismatch has an effect, 
although it is relatively minor when the mismatch is small.  One should note that the lesions were 
typically on the order of 10 cm from the FOV center for the PET/CT phantom images acquired 
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for the observer study.  Figure 8 shows similar trends for TBR recovery versus ROI size 
mismatch as those observed with the results shown in Figure 7. 
5.2 IMPACT OF CORRECTION SCHEME ON OBSERVER PERFORMANCE 
The impact of PVE correction was measured for human observers and a numerical observer.  
Here, ratings data for all acquisition mode and reconstruction algorithm combinations were 
pooled.  Note that the physicians were clinically experienced in reading PET/CT images while 
the medical physicists were not.  The numerical observer categorized each PET/CT image, with 
or without PVE correction, by average TBR only without the possibility of subjective judgment 
calls. The implementation of the numerical observer was described in section 4.3.3. 
5.2.1  Effect of the SUV Correction Scheme on Human Observers 
Table 4 presents the Az results for the MLCS both without and with the SUV correction 
scheme.  Performance, as measured by Az values, did not improve or worsen with the addition of  
Table 4:  Az using PET/CT data 
MLCS MLCS, corrected 
TBR 
MLCS MLCS, corrected 
TBR 
Nuclear medicine physicians All physicians 
0.80 ± 0.04 0.84 ± 0.03 0.83 ± 0.03 0.83 ± 0.02 
Radiation  oncologists Medical physicists 
0.87 ± 0.03 0.82 ± 0.03 0.90 ± 0.05 0.86 ± 0.03 
a corrected TBR.  With the corrected TBR, Az values for the medical physicists were statistically 
no different than the Az values for the physicians.  TPF vs. FPF data and fitted ROC curves from 
the MLCS using corrected and uncorrected PET/CT data are displayed in Figure 9.  
Qualitatively, for all observers, the ROC curves for the MLCS without PVE correction and for 
the MLCS with correction appear to overlap (Figure 9).  Once given a corrected TBR, observers 
gave more positive ratings, both correctly and incorrectly, which shifted data points up and to the 
right.  Sensitivity was increased at the most difficult decision thresholds for most ROC curves 
and data.  For example, the medical physicists had 98.8% sensitivity on the hardest decision 
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threshold using the corrected PET data, with a corresponding specificity of 45.4%.  Values for 
the other observer groups were similar. 
 
Figure 9:  Data for the MLCS using uncorrected (black symbols) and corrected (red symbols) 
PET/CT data.  Lines connecting symbols (uncorrected data:  dashed black line; corrected 
data: dashed red line) are for visual aid only as the data are not continuous.  First, second, 
third, and fourth decision thresholds correspond to the asterisk, diamond, triangle, and 
square symbols, respectively.  Solid black lines and red lines are fitted ROC curves 
representing studies without and with PVE correction, respectively. 
Table 5 summarizes the sensitivity, specificity and accuracy results for the MLCS both 
without and with the SUV correction scheme. For all observers, the corrected TBRs significantly 
(the values are further than two standard deviations apart) increased sensitivity by 44.4% for 
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physicians and 65% for medical physicists. Corrected TBRs produced a marginal increase in 
accuracy for physicians and significantly increased accuracy for medical physicists.  Corrected 
TBRs caused a significant decrease in specificity, between 15 and 17 percent for all groups of 
observers.  The physicians’ pooled MLCS data exhibited marginally higher sensitivity and 
accuracy with uncorrected TBRs than the medical physicists.  The medical physicists appeared to 
score better on sensitivity than the physicians when using the corrected TBRs, but without 
statistical significance.  
Table 5:  Percent sensitivity, specificity, and accuracy using PET/CT data 
MLCS MLCS, corrected TBR 
Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
Nuclear medicine physicians 
23.8 ± 5.0 100 ± 0.0 70.7 ± 1.9 68.8 ± 7.2 84.4 ± 0.9 78.4 ± 2.8 
Radiation oncologists 
26.2 ± 5.2 99.3 ± 0.0 71.2 ± 2.0 70.0 ± 7.2 82.1 ± 1.1 77.4 ± 2.9 
All physicians 
25.0 ± 3.6 96.1 ± 0.0 70.9 ± 1.4 69.4 ± 5.1 83.3 ± 0.7 77.9 ± 2.0 
Medical physicists 
12.5 ± 3.8 100 ± 0.0 66.3 ± 1.4 77.5 ± 6.9 76.6 ± 1.7 76.9 ± 2.9 
 
5.2.2  Classification Using a Numerical Observer 
Using uncorrected TBRs, the numerical observer was unable to correctly identify any 
actually positive lesions (Table 6) because the uncorrected TBRs were never above 2.5.  Figure  
Table 6:  Percent sensitivity, specificity, and accuracy for the numerical observer using a 
threshold of 2.5 TBR, using the observer drawn ROIs 
MLCS MLCS, corrected TBR 
Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
0.0* 100 ± 0.0 60.0* 53.1 ± 7.8 82.3 ± 6.0 70.6 ± 4.8 
*Lack of true positives caused division by zero in calculation of variation 
 
10 illustrates this issue by plotting uncorrected and corrected TBRs versus lesion volumes and 
actual TBRs.  Figure 10 also illustrates how errors in ROI size result in errors in corrected SUV.  
When presented with a corrected TBR, the numerical observer was more successful at 
identifying actually positive lesions than when presented with an uncorrected TBR, as illustrated 
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by the sensitivity results in Table 6.  When using corrected TBRs, specificity significantly 
decreased by 17.7%, and accuracy increased by 10.6%; the change in accuracy is probably not 
significant, if one assumes a comparable level of error as for the calculated accuracy with 
uncorrected TBRs. (Note that this significance cannot be assessed directly because the lack of 
any true positives by the numerical observer prevents the calculation of variance for accuracy 
with uncorrected TBRs.) 
The numerical observer, when using the dilated version of the human observers’ ROIs, had a 
similar accuracy, sensitivity, and specificity it did when using the ROIs as drawn, as seen in 
Table 7.  When using the eroded ROIs, the numerical observer scored the same on accuracy and 
sensitivity as when using the drawn ROIs, but had a decreased specificity. 
 
Figure 10:  Each graph plots the average volumes (mL) of the ROIs drawn by the observers 
versus the average TBRs in these ROIs.  Diamonds represent uncorrected TBRs and 
triangles represent corrected TBRs.  Error bars for these points represent the standard 
deviation of the average TBR (vertical bars) and ROI volume (horizontal bars).  Dotted 
lines connect the plotting symbols to the corresponding true lesion volumes and TBRs 
(blue long-dashed lines).  The red short-dashed horizontal line represents a TBR of 2.5. 
 
The percent recovered TBR for uncorrected and corrected TBRs were tabulated for all actual 
sizes and actual TBRs, for the observer drawn ROIs (Table 8) and the dilated and eroded ROIs 
(Table 9).  The percent recovered TBR was closer to 100% for corrected TBRs than uncorrected 
TBRs for 74 out of 76 of the drawn ROIs, 75 out of 76 of the dilated ROIs, and 68 out of 76 of 
the eroded ROIs.  On average, the uncorrected percent recovered TBR was only 15.1% while the 
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average corrected TBR was 100%, 125%, and 210% for the dilated, observer drawn, and eroded 
ROIs, respectively.  This implies that the observers generally drew their ROIs slightly too small. 
Table 7:  Percent sensitivity, specificity, and accuracy for the numerical observer using a 
threshold of 2.5 TBR and using dilated and eroded ROIs 
Dilated ROIs Eroded ROIs 
Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
53.1 ± 7.8 81.3 ± 6.1 70.0 ± 4.8 59.4 ± 8.0 68.8 ± 6.6 65.0 ± 5.1 
 
Table 8:  Average recovered uncorrected and corrected TBRs, as a percentage of the actual TBR, 
for observer-drawn ROIs for all actual lesion sizes and TBRs.  
  0.125 mL 0.25 mL 0.5 mL 1.0 mL 2.0 mL Mean 
1.08 TBR Uncorrected 15.3 3.6 12.6 23.7 32.1 17.5 
Corrected 183 33.9 165 158 109 130 
1.72 TBR Uncorrected 7.5 13.9 12.4 14.1 25.3 14.7 
Corrected 205 281 111 146 107 170 
4.04 TBR Uncorrected 3.4 9.8 9.8 16.2 29.0 13.6 
Corrected 51.2 199 59.4 81.5 113 101 
7.56 TBR Uncorrected 4.9 8.0 13.1 21.1 25.3 14.5 
Corrected 137 62.9 142 95.8 67.7 101 
Mean Uncorrected 7.8 8.8 12.0 18.8 27.9 15.1 
Corrected 144 144 119 120 99.1 125 
 
Table 9:  Average recovered corrected TBRs, expressed as a percentage of the actual TBR, for 
dilated and eroded ROIs. 
  0.125 mL 0.25 mL 0.5 mL 1.0 mL 2.0 mL Mean 
1.08 TBR Dilated 146 28.4 154 142 101 114 
Eroded 283 42.5 233 200 119 176 
1.72 TBR Dilated 123 202 98.8 138 94.9 131 
Eroded 459 486 143 184 119 278 
4.04 TBR Dilated 32.2 133 51.9 70.4 100 77.5 
Eroded 112 404 80.7 103 122 164 
7.56 TBR Dilated 71.0 48.5 121 84.1 63.6 77.7 
Eroded 651 82.0 167 128 71.9 220 
Mean Dilated 93.1 103 106 109 89.9 100 
Eroded 376 254 156 154 108 210 
 
The correction scheme produced overestimates of TBR in some situations, but 
underestimates of TBR in others (Table 10).  Overall, underestimation of the corrected TBR was 
more likely to occur than overestimation. Under- or overestimation of corrected TBR had no 
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obvious trends with either lesion size or actual TBR.  Underestimation by the corrected TBR 
occurred more often than overestimation when the observer drawn ROI was too large compared 
to the actual lesion size, which agreed with the results from the characterization simulations.  
Table 10:  Correlation between ROI size and correction accuracy versus actual lesion size and 
TBR.  Percent occurrence is given per each actual lesion size or actual TBR.  
Lesion 
size 
[mL] 
Drawn ROI too small Drawn ROI too large 
Underestimated 
TBR 
Overestimated TBR Underestimated 
TBR 
Overestimated TBR 
0.125 34.2 % 13.7 % 34.2 % 17.8 % 
0.25 19.1 % 13.8 % 40.4 % 26.6 % 
0.5 13.0 % 17.4 % 35.9 % 33.7 % 
1.0 15.1 % 15.1 % 35.5 % 34.4 % 
2.0 19.8 % 9.9 % 51.6 % 18.7 % 
Actual 
TBR 
Underestimated 
TBR 
Overestimated TBR Underestimated 
TBR 
Overestimated TBR 
1.08 24.8 % 24.8 % 32.4 % 29.5 % 
1.72 14.4 % 14.4 % 23.4 % 41.4 % 
4.04 17.5 % 17.5 % 52.6 % 15.8 % 
7.56 22.1 % 22.1 % 49.6 % 20.4 % 
 
However, when ROI size was smaller than the lesion size, the simulation predicted that 
overestimation was more likely to occur. This finding with the experimental results may be due 
to the correction scheme PSF being less broad than the PET scanner PSF. The narrow correction 
scheme over-corrects for the effect of the too-small ROI. 
5.3 IMPACT OF ACQUISITION MODE AND RECONSTRUCTION 
ALGORITHM ON OBSERVER PERFORMANCE 
The impact of acquisition mode and reconstruction algorithm selection was measured for 
human observers and the numerical observer in terms of lesion detection and malignant lesion 
classification.  PET data, PET/CT data, and PET/CT data with PVE correction were evaluated.  
As mentioned previously, the physicians were clinically experienced in reading PET/CT images 
while the medical physicists were not.  The numerical observer assessed each PET/CT image, 
with or without PVE correction, by average TBR only, without the possibility of subjective 
judgment calls. 
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5.3.1 Effect of Acquisition Mode and Reconstruction Algorithm Selection Using 
PET Data Alone 
The nuclear medicine physicians who took part in this study only use a 3D mode scanner and 
reconstruct PET images with OSEM in their daily clinical practice.  Using their responses on the 
PET data, Az for the 3D OSEM and 3D FBP algorithms were not significantly different for the 
LDS (p = 0.52) but were marginally different for the MLCS (p = 0.07).  The radiation 
oncologists who took part in this study almost exclusively use the 2D mode on the Discovery ST 
scanner and reconstruct PET images with OSEM.  Using their responses on the PET data, the 
differences in Az between FBP and OSEM modes with 2D acquisition were not significantly 
different for either the LDS (p = 0.85) or MLCS (p = 0.68).  Table 11 summarizes Az results for 
these two groups of observers using PET data only.  
Table 11:  Az for physicians using PET data only 
 Nuclear medicine physicians Radiation oncologists 
 LDS MLCS LDS MLCS 
2D FBP 0.67 ± 0.08 0.75 ± 0.08 0.60 ± 0.08 0.65 ± 0.09 
2D OSEM 0.64 ± 0.09 0.77 ± 0.08 0.58 ± 0.09 0.60 ± 0.11 
3D FBP 0.68 ± 0.08 0.61 ± 0.09 0.44 ± 0.08 0.70 ± 0.09 
3D OSEM 0.74 ± 0.07 0.83 ± 0.07 Degenerate† 0.72 ± 0.10 
†Marginal data 
 
For the LDS, the nuclear medicine physicians using 3D OSEM data had a higher Az than the 
radiation oncologists using 2D OSEM data, although not significantly higher (p = 0.17).  For the 
MLCS, the nuclear medicine physicians’ 3D OSEM ROC curve had a higher Az than the 
radiation oncologists’ 2D OSEM ROC curve with marginal significance (p = 0.07) 
However, ROC data pooled for all physicians showed a significant difference between 3D 
FBP and 3D OSEM reconstructions for the LDS (p = 0.03), with 3D OSEM outperforming 3D 
FBP.  For the MLCS, 3D OSEM and 3D FBP were not significantly different (p = 0.18).  Table 
12 summarizes these pooled Az results for the physicians and also for the medical physicists 
using PET data only.  Performance for 3D OSEM and 3D FBP were not significantly different (p 
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= 0.18) however.  Much of the medical physicists’ data failed to produce valid ROC curves and 
Az values because the physicists rarely responded with ratings other than the two extreme values 
(definitely negative or definitely positive).  TPF vs. FPF for several decision thresholds for the 
LDS using PET data only is displayed in Figure 11; the corresponding MLCS data is displayed 
in Figure 12.  For all of the plots, notice the lack of points in the higher false positive range, 
especially for the MLCS, and the vertical grouping between different thresholds.  Some of the 
observers noted that they were having trouble finding the lesions in the PET only data.  Despite 
the lack of activity in the surrounding simulated lung tissue, distinguishing lesions from 
background was apparently difficult.  The difficulty of the data set appears to skew the ROC 
results with many false negatives, few false positives, and consequently low sensitivity. Vertical 
grouping of the ROC data points prevented the ROCKIT software from generating fitted ROC 
curves in some cases (Table 12). Improving the data set would require adding more images  
Table 12:  Az for all observers using PET data only 
 All physicians Medical physicists 
 LDS MLCS LDS MLCS 
2D FBP 0.63 ± 0.06 0.70 ± 0.06 ROCKIT failed Degenerate† 
2D OSEM 0.61 ± 0.06 0.68 ± 0.07 Degenerate† 0.88 ± 0.11 
3D FBP 0.56 ± 0.06 0.66 ± 0.07 Degenerate† Degenerate† 
3D OSEM 0.75 ± 0.07 0.78 ± 0.06 0.65 ± 0.09 0.77 ± 0.15 
†Marginal data 
spanning a larger range of TBRs and tumor sizes; this increase in the data set size would result in 
a substantially larger time commitment on the part of the observers to complete the study. This 
was not deemed practical within the context of the current project.  
Table 13 summarizes the results for sensitivity, specificity, and accuracy for the two groups 
of physicians for the MLCS and LDS using PET data.  Again, to calculate these values for each 
observer, the two most positive responses and the three most negative responses from the 
observer study were lumped together.  When referring to statistical significances between these  
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Figure 11:  Data for the LDS using PET data only.  Black lines represent 2D FBP, red lines 
represent 2D OSEM, blue lines represent 3D FBP, and green lines represent 3D OSEM.  
First, second, third, and fourth decision thresholds correspond to the asterisk, diamond, 
triangle, and square shapes, respectively; the lines connecting the symbols are for visual 
aid only. 
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Figure 12:  Data for the MLCS using PET data only.  Black lines represent 2D FBP, red lines 
represent 2D OSEM, blue lines represent 3D FBP, and green lines represent 3D OSEM.  
First, second, third, and fourth decision thresholds correspond to the asterisk, diamond, 
triangle, and square shapes, respectively; the lines connecting the symbols are for visual 
aid only. 
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Table 13:  Percent sensitivity, specificity, and accuracy for nuclear medicine physicians and 
radiation oncologists using PET data only  
Nuclear medicine physicians 
 LDS MLCS 
 Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
2D FBP 34.2 ±  8.5 100 ± 0.0 53.7 ± 6.0 20.0 ± 9.3 97.1 ± 4.9 68.5 ± 4.6 
2D OSEM 28.9 ± 7.9 100 ±  0.0 50.0 ± 5.6 30.0 ± 11.1 100 ± 0.0 74.1 ± 4.1 
3D FBP 30.0 ±  7.9 100 ± 0.0 44.0 ± 6.3 10.0 ± 6.8 93.3 ± 7.5 60.0 ± 5.3 
3D OSEM 42.5 ±  9.1 100 ± 0.0 54.0 ± 7.3 35.0 ± 12.0 100 ± 0.0 74.0 ± 4.8 
Radiation oncologists 
 LDS MLCS 
 Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
2D FBP 21.1 ± 6.9 100 ± 0.0 44.4 ± 4.9 30.0 ± 11.1 94.1 ± 6.7 70.4 ± 5.9 
2D OSEM 21.1 ±  6.9 100 ± 0.0 44.4 ± 4.9 35.0 ± 12.0 100 ± 0.0 75.9 ± 4.4 
3D FBP 20.0 ± 6.6 100 ± 0.0 36.0 ± 5.2 35.0 ± 12.0 96.7 ± 5.6 72.0 ± 5.9 
3D OSEM 22.5 ±  6.9 100 ± 0.0 38.0 ± 5.5 40.0 ± 12.6 100 ± 0.0 76.0 ± 5.0 
 
values, no significance means that the pair of values lie within each others’ standard deviation, 
marginal significance means that the values overlap between one and two standard deviations, 
and significance means that the values are further than two standard deviations apart.  The 
nuclear medicine physicians performed marginally better using 3D OSEM than 3D FBP for 
sensitivity and accuracy for the MLCS when using only PET data.  The radiation oncologists 
fared slightly better using 2D OSEM than 2D FBP on the MLCS with respect to sensitivity, 
specificity, and accuracy using although not significantly.  The nuclear medicine physicians had 
a marginally higher sensitivity for the LDS using 3D OSEM than the radiation oncologists had 
using 2D OSEM in the LDS.  Table 14 summarizes the LDS and MLCS results when using PET 
data only for the physicians as a group and for the medical physicists, for which no mode fared 
significantly better than any other.  A specificity of 100% with zero variation, which is seen in 
these tables is caused by the lack of false positives in this difficult image data set, as mentioned 
previously. 
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Table 14:  Percent sensitivity, specificity, and accuracy for physicians and medical physicists 
using PET data only 
All physicians 
 LDS MLCS 
 Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
2D FBP 27.6 ± 5.5 100 ± 0.0 49.1 ± 3.9 25.0 ± 7.3 95.6 ± 4.2 69.4 ± 3.8 
2D OSEM 25.0 ± 5.3 100 ± 0.0 47.2 ± 3.7 32.5 ± 8.2 100 ± 0.0 75.0 ± 3.0 
3D FBP 25.0 ±  5.1 100 ± 0.0 40.0 ± 4.1 22.5 ± 6.9 95.0 ± 4.7 68.0 ± 4.0 
3D OSEM 32.5 ±  5.8 100 ± 0.0 46.0 ± 4.6 37.5 ± 8.7 100 ± 0.0 75.0 ± 3.5 
Medical physicists 
 LDS MLCS 
 Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
2D FBP 15.8 ± 6.1 100 ± 0.0 40.7 ± 4.3 10.0 ± 6.8 100 ± 0.0 66.7 ± 2.5 
2D OSEM 26.3 ±  7.6 100 ± 0.0 48.1 ± 5.4 20.0 ± 9.3 100 ± 0.0 70.4 ± 3.4 
3D FBP 20.0 ±  6.6 100 ± 0.0 36.0 ± 5.3 5.0 ± 4.9 100 ± 0.0 62.0 ± 2.0 
3D OSEM 20.0 ± 6.6 100  ± 0.0 36.0 ± 5.3 20.0 ± 9.3 100 ± 0.0 68.0 ± 3.7 
 
5.3.2  Effect of Acquisition Mode and Reconstruction Algorithm Selection Using 
PET/CT Data 
The Az values for the LDS using PET/CT data (Table 15) were generally higher than the Az 
values for the LDS using PET data alone (Tables 11 and 12) for the nuclear medicine physicians.  
However, much of the data for radiation oncologists and medical physicists failed to produce a 
valid ROC curve due to poor grouping of observer ratings; other than the nuclear medicine 
Table 15:  Az using PET/CT data for the LDS 
 Nuclear medicine 
physicians 
Radiation  
oncologists 
All physicians Medical physicists 
2D FBP 0.80 ± 0.07 ROCKIT failed 0.80 ± 0.05 Degenerate† 
2D OSEM 0.71 ± 0.09 Degenerate† 0.78 ± 0.07 0.66 ± 0.08 
3D FBP 0.65 ± 0.08 Degenerate† 0.70 ± 0.06 Degenerate† 
3D OSEM Degenerate† Degenerate† Degenerate† Degenerate† 
†Marginal data 
 
physicians, observers tended to rate lesion detection as either definitely positive or definitely 
negative with few ratings in between.  TPF vs. FPF for several decision thresholds for the LDS 
using PET/CT data is displayed in Figure 13.  Again, lack of false positives caused vertical 
grouping of ROC data points.  Because of this grouping, ROCKIT failed to produce fitted ROC 
curves for some cases.  With the addition of CT data, no ROC data or fitted ROC curve appeared 
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to outperform any other, with the exception of the 2D FBP curve for the nuclear medicine 
physicians. 
In terms of sensitivity, specificity, and accuracy, no modality outperformed any other in the 
LDS for any observer type when using PET/CT data.  Table 16 summarizes sensitivity, 
specificity, and accuracy results for the LDS study using PET/CT data. 
 
Figure 13:  Results for the LDS using PET/CT data.  Black lines represent 2D FBP, red lines 
represent 2D OSEM, blue lines represent 3D FBP, and green lines represent 3D OSEM.  
First, second, third, and fourth decision thresholds correspond to the asterisk, diamond, 
triangle, and square shapes, respectively; the lines connecting the symbols are for visual 
aid only. 
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Table 16:  Percent sensitivity, specificity, and accuracy for all observers using PET/CT data for 
the LDS  
 Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
 Nuclear medicine physicians All physicians 
2D FBP 42.1 ± 9.3 100 ± 0.0 59.3 ± 6.6 34.2 ± 6.0 100 ± 0.0 53.7 ± 4.3 
2D OSEM 39.5 ± 9.1 93.8 ± 10.0 55.6 ± 7.1 32.9 ± 5.9 96.9 ± 5.2 51.9 ± 4.5 
3D FBP 30.0 ± 7.9 100 ± 0.0 44.0 ± 6.3 26.3 ± 5.2 100 ± 0.0 41.0 ± 4.2 
3D OSEM 27.5 ± 7.6 100 ± 0.0 42.0 ± 6.1 26.3 ± 5.2 100 ± 0.0 41.0 ± 4.2 
 Radiation  oncologists Medical physicists 
2D FBP 26.3 ± 7.6 100 ± 0.0 48.1 ± 5.4 21.1 ± 6.9 100 ± 0.0 44.4 ± 4.9 
2D OSEM 26.3 ± 7.6 100 ± 0.0 48.1 ± 5.4 26.3 ± 7.6 100 ± 0.0 48.1 ± 5.4 
3D FBP 22.5 ± 6.9 100 ± 0.0 38.0 ± 5.5 20.0 ± 6.6 100 ± 0.0 36.0 ± 5.3 
3D OSEM 25.0 ± 7.3 100 ± 0.0 40.0 ± 5.8 22.5 ± 6.9 100 ± 0.0 38.0 ± 5.5 
 
Az values for the MLCS were generally higher with the addition of correlated CT data.  No 
Az value was significantly higher than any other, as shown in Table 17.  Again, some of the ROC  
Table 17:  Az values for the MLCS using PET/CT data 
 Nuclear Medicine 
Physicians 
Radiation  
Oncologists 
All Physicians Medical Physicists 
2D FBP 0.78 ± 0.08 0.87 ± 0.06 0.82 ± 0.05 0.91 ± 0.06 
2D OSEM 0.86 ± 0.05 0.76 ± 0.09 0.77 ± 0.06 Degenerate† 
3D FBP Degenerate† 0.91 ± 0.05 0.85 ± 0.06 Degenerate† 
3D OSEM Degenerate† 0.94 ± 0.04 0.88 ± 0.05 Degenerate* 
*Perfect performance implied 
†Marginal data 
 
data was degenerate due to observers never giving false positive decisions, as seen by the vertical 
grouping of the data in Figure 14.  Table 18 shows that sensitivity, specificity, and accuracy were 
not significantly different between any acquisition mode or reconstruction method.  
Qualitatively, the ROC data for each combination of acquisition mode and reconstruction 
algorithm appear to overlay one another as shown in Figure 14.   
5.3.3  Effect of Acquisition Mode and Reconstruction Algorithm Selection Using 
PET/CT Data with PVE Correction 
When the PVE correction scheme was used, no acquisition mode and reconstruction algorithm 
combination or observer type outperformed any other in terms of Az (Table 19).  Nor did any 
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Figure 14:  Data for the MLCS using PET/CT data.  Black lines represent 2D FBP, red lines 
represent 2D OSEM, blue lines represent 3D FBP, and green lines represent 3D OSEM.  
First, second, third, and fourth decision thresholds correspond to the asterisk, diamond, 
triangle, and square shapes, respectively; the lines connecting the symbols are for visual 
aid only. 
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Table 18:  Percent sensitivity, specificity, and accuracy for all observers using PET/CT data for 
the MLCS 
 Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
 Nuclear medicine physicians All physicians 
2D FBP 20.0 ± 9.3 100 ± 0.0 70.4 ± 3.4 20.0 ± 6.6 100 ± 0.0 70.4 ± 2.4 
2D OSEM 30.0 ± 11.1 100 ± 0.0 74.1 ± 4.1 30.0 ± 7.9 98.5 ± 2.5 73.1 ± 3.3 
3D FBP 15.0 ± 8.2 100 ± 0.0 66.0 ± 3.3 20.0 ± 6.6 100 ± 0.0 68.0 ± 2.6 
3D OSEM 30.0 ± 11.1 100 ± 0.0 72.0 ± 4.5 30.0 ± 7.9 100 ± 0.0 72.0 ± 3.1 
 Radiation  oncologists Medical physicists 
2D FBP 20.0 ± 9.3 100 ± 0.0 70.4 ± 3.4 10.0 ± 6.8 100 ± 0.0 66.7 ± 2.5 
2D OSEM 30.0 ± 11.1 97.1 ± 4.9 72.2 ±5.2 20.0 ± 9.3 100 ± 0.0 70.4 ± 3.4 
3D FBP 25.0 ± 10.3 100 ± 0.0 70.0 ± 4.1 5.0 ± 4.9 100 ± 0.0 62.0 ± 2.0 
3D OSEM 30.0 ± 11.1 100 ± 0.0 72.0 ± 4.5 15.0 ± 8.2 100 ± 0.0 66.0 ± 3.3 
 
combination of acquisition mode and reconstruction algorithm or observer type outperform any 
other in terms of sensitivity, specificity, or accuracy with any significance (Table 20).  
Qualitatively, the ROC data for each combination of acquisition mode and reconstruction 
algorithm appear to overlay one another, as shown in Figure 15.  Given PET/CT data with PVE 
correction, there was no inter-observer variation or effect of acquisition mode and reconstruction 
algorithm on the diagnostic performance. 
Table 19:  Az values for the MLCS using PET/CT data with corrected PET data 
 Nuclear medicine 
physicians 
Radiation  
oncologists 
All physicians Medical physicists 
2D FBP 0.86 ± 0.05 0.83 ± 0.06 0.84 ± 0.04 0.84 ± 0.06 
2D OSEM 0.79 ± 0.07 0.86 ± 0.05 0.82 ± 0.04 0.86 ± 0.05 
3D FBP 0.86 ± 0.06 0.80 ± 0.07 0.83 ± 0.04 0.86 ± 0.05 
3D OSEM 0.83 ± 0.06 0.82 ± 0.06 0.82 ± 0.04 0.89 ± 0.05 
 
5.3.4  Effect of Acquisition Mode and Reconstruction Algorithm Selection on the 
Numerical Observer  
The numerical observer performed exactly the same for all combinations of acquisition mode 
and reconstruction algorithm when working without PVE correction (Table 21).  Furthermore, 
when the numerical observer used PVE correction, its diagnostic performance, in terms of 
sensitivity, specificity, or accuracy did not vary between combinations of acquisition mode and 
reconstruction algorithm.  When using dilated or eroded ROIs, diagnostic performance still was 
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not significantly different between combinations of acquisition mode and reconstruction 
algorithm (Table 22). 
 
Figure 15:  Data for the MLCS using PET/CT data with corrected PET data.  Black lines 
represent 2D FBP, red lines represent 2D OSEM, blue lines represent 3D FBP, and green 
lines represent 3D OSEM.  First, second, third, and fourth decision thresholds correspond 
to the asterisk, diamond, triangle, and square shapes, respectively; the lines connecting 
the symbols are for visual aid only. 
 
While diagnostic performance did not vary between combinations of acquisition mode and 
reconstruction algorithm, quantitative accuracy did vary.  The only two cases where the 
uncorrected TBR was closer to the actual TBR than the corrected TBR using an observer drawn 
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Table 20:  Percent sensitivity, specificity, and accuracy using PET/CT data with corrected PET 
data for the MLCS 
 Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
 Nuclear medicine physicians All physicians 
2D FBP 80.0 ± 13.5 82.4 ± 10.0 81.5 ± 8.1 77.5 ± 9.8 82.4 ± 7.1 80.6 ± 5.8 
2D OSEM 55.0 ± 14.1 88.2 ± 8.8 75.9 ± 7.6 57.5 ± 10.1 85.3 ± 6.7 75.0 ± 5.6 
3D FBP 75.0 ± 14.1 80.0 ± 11.0 78.0 ± 8.7 72.5 ± 10.1 83.3 ± 7.4 79.0 ± 6.0 
3D OSEM 65.0 ± 14.5 86.7 ± 9.8 78.0 ± 8.3 70.0 ± 10.2 81.7 ± 7.6 77.0 ± 6.1 
 Radiation  oncologists Medical physicists 
2D FBP 75.0 ± 14.1 82.4 ± 10.0 79.6 ± 8.2 80.0 ± 13.5 70.6 ± 11.0 74.1 ± 8.6 
2D OSEM 60.0 ± 14.4 82.4 ± 10.0 74.1 ± 8.3 75.0 ± 14.1 82.4 ± 10.0 79.6 ± 8.2 
3D FBP 70.0 ± 14.4 86.7 ± 9.8 80.0 ± 8.2 75.0 ± 14.1 73.3 ± 11.6 74.0 ± 9.0 
3D OSEM 75.0 ± 14.1 76.7 ± 11.4 76.0 ± 8.9 80.0 ± 13.5 80.0 ± 11.0 80.0 ± 8.5 
 
Table 21:  Percent sensitivity, specificity, and accuracy for numerical observer using a threshold 
of 2.5 TBR 
 MLCS MLCS, corrected TBR 
 Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
2D FBP 0.0* 100 ± 0.0 60.0* 50.0 ± 15.3 75.0 ± 12.9 65.0 ± 9.9 
2D OSEM 0.0* 100 ± 0.0 60.0* 50.0 ± 15.4 87.5 ± 10.7 72.5 ± 8.9 
3D FBP 0.0* 100 ± 0.0 60.0* 56.3 ± 15.8 79.2 ± 12.4 70.0 ± 9.8 
3D OSEM 0.0* 100 ± 0.0 60.0* 56.3 ± 15.8 87.5 ± 10.7 75.0 ± 9.0 
*Lack of true positives caused division by zero in calculation of variation 
 
Table 22:  Percent sensitivity, specificity, and accuracy for numerical observer in the MLCS 
using a threshold of 2.5 TBR and using dilated and eroded ROIs 
 Dilated ROIs Eroded ROIs 
 Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
2D FBP 50.0 ± 15.3 75.0 ± 12.9 65.0 ± 9.9 62.5 ± 16.1 70.8 ± 13.1 67.5 ± 10.2 
2D OSEM 43.8 ± 14.6 91.7 ± 9.2 72.5 ± 8.0 50.0 ± 15.3 75.0 ± 12.9 65.0 ± 9.9 
3D FBP 50.0 ± 15.3 83.3 ± 11.8 70.0 ± 9.3 62.5 ± 16.2 79.2 ± 12.4 72.5 ± 9.9 
3D OSEM 56.3 ± 15.8 87.5 ± 10.7 75.0 ± 9.0 56.3 ± 15.8 79.2 ± 12.4 70.0 ± 9.8 
 
ROI were when the images in question were reconstructed with FBP.  These cases are 
highlighted in bold in Table 23.  Using dilated ROIs, there was only one case where the 
uncorrected TBR was closer to the actual TBR than the corrected TBR.  Of the eight eroded 
ROIs where the uncorrected TBR was closer to the actual TBR than the corrected TBR, six were 
reconstructed with FBP and two were reconstructed with OSEM.  These cases are highlighted in 
bold in Table 24.   
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Corrected TBRs were closer, on average, to actual TBRs and varied less for images 
reconstructed with OSEM than those reconstructed with FBP (Table 25 and Figure 16).  This 
was true for both observer drawn and dilated ROIs, but not for eroded ROIs.  
5.4 IMPACT OF THE ADDITION OF CORRELATED CT DATA TO PET 
DATA ON OBSERVER PERFORMANCE 
The addition of correlated CT data to the PET data enhanced diagnostic performance for all 
observer types, as measured by Az values, for both the LDS (Table 26) and MLCS (Table 27).  
Also, qualitatively, the ROC curves for all observers when PET/CT data were used lay above the 
curves obtained when PET data alone were used (Figure 17 for the LDS and Figure 18 for the 
MLCS).  This enhancement seen in diagnostic performance was in accord with other studies (24) 
(25) (26) (27) (28).  
However, when the impact of viewing PET data simultaneously with CT data was evaluated 
in terms of sensitivity, specificity, and accuracy, no statistically significant improvement was 
seen for any observer type in either the LDS or MLCS (Table 28 for the LDS and Table 29 for 
the MLCS).  The sensitivities, specificities, and accuracies evaluated correspond to the diamond 
shape seen in the plots in Figures 17 and 18.  If these values were evaluated at another decision  
threshold, e.g. the decision threshold with the highest FPF (the square shapes in Figures 17 and 
18), diagnostic performance was enhanced with the addition of correlated CT data.  In most of 
the plots in Figures 17 and 18, the red square for the PET/CT data lay closer to the top left corner 
of the ROC square (meaning increased TPF at all FPFs) than the black square for the PET only 
data. 
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Table 23:  Percent recovered mean uncorrected and corrected TBRs using mean value from all 
observer-drawn ROIs.  Boldface numbers highlight where uncorrected TBRs were closer 
to 100% than the corrected TBRs. 
  1.08 TBR 1.72 TBR 4.04 TBR 7.56 TBR Mean 
 [mL] Corre
cted 
Uncor
rected 
Corre
cted 
Uncor
rected
Corre
cted 
Uncor
rected
Corre
cted 
Uncor
rected 
Corre
cted 
Uncor
rected 
2D
 F
B
P 
0.125 * * 1.1 9.0 3.2 50.9 5.8 66.5 3.4 42.1 
0.25 2.1 25.4 23.6 415 6.9 86.8 8.8 75.7 10.4 151 
0.5 19.8 284 16.2 112 10.7 58.3 9.0 131 13.9 147 
1 36.8 310 15.7 152 15.2 104 18.9 71.9 21.7 160 
2 31.7 132 44.9 211 27.7 92.4 23.4 67.1 31.9 126 
2D
 O
SE
M
 0.125 * * 6.0 62.3 5.1 68.8 2.0 22.1 4.5 51.1 
0.25 7.0 72.7 13.4 375 7.7 102 8.4 69.8 9.1 155 
0.5 13.0 167 14.1 105 8.6 33.8 11.3 90.0 11.8 99.1 
1 20.1 202 12.7 113 13.5 75.4 20.0 79.5 16.6 118 
2 27.2 131 24.1 109 33.1 104 29.8 83.6 28.6 107 
3D
 F
B
P 
0.125 4.0 45.6 19.3 647 2.5 61.7 6.3 317 7.3 268 
0.25 2.1 16.4 8.0 126 15.0 343 7.7 57.6 8.2 136 
0.5 9.0 111 13.1 153 9.8 71.3 16.8 176 12.2 128 
1 20.2 62.9 16.1 187 16.2 71.3 20.4 104 18.2 107 
2 33.4 83.5 15.2 53.3 24.5 128 20.8 51.6 23.5 79.2 
3D
 O
SE
M
 0.125 26.6 320 3.8 99.5 2.9 23.4 5.3 143 9.7 147 
0.25 3.14 21.3 10.8 205 9.4 263 7.3 48.7 7.7 135 
0.5 8.5 98.4 6.2 72.8 10.3 74.3 15.3 171 10.1 104 
1 17.8 54.5 12.0 132 19.9 75.3 25.1 127 18.7 97.2 
2 36.3 87.3 17.0 55.3 30.6 125 27.0 68.5 27.7 84 
Mean 17.5 130 14.7 170 13.6 101 14.5 101.2 15.1 125 
* No ROI drawn by human observers for this set 
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Table 24:  Percent recovered corrected mean TBRs using mean value from all dilated and eroded 
 observer drawn ROIs.  Boldface numbers highlight where uncorrected TBRs were closer 
 to 100% than the corrected TBRs. 
  1.08 TBR 1.72 TBR 4.04 TBR 7.56 TBR Mean 
 [mL] Dilat-
ed 
Erod-
ed 
Dilat-
ed 
Erod-
ed 
Dilat-
ed 
Erod-
ed 
Dilat-
ed 
Erod-
ed 
Dilat-
ed 
Erod-
ed 
2D
 F
B
P 
0.125 * * 6.1 17.6 32.0 131 52.8 97.6 30.3 82.1 
0.25 19.7 25.0 304 845 66.9 92.2 58.7 106 112 269 
0.5 267 418 95.8 137 51.1 94.1 107 172 246 205 
1 279 398 146 183 90.8 136 63.0 87.4 145 201 
2 124 144 192 233 86.8 103 63.7 71.4 117 138 
2D
 O
SE
M
 0.125 * * 48.4 126 45.8 130 18.5 29.5 37.6 95.2 
0.25 63.8 89.7 257 761 82.1 104 56.3 86.9 115 260 
0.5 157 240 83.3 135 31.4 46.3 75.3 119 86.8 135 
1 181 257 104 152 63.8 99.2 69.6 96.8 105 151 
2 121 145 95.0 121 96.6 118 78.9 85.3 97.9 117 
3D
 F
B
P 
0.125 38.5 67.5 376 1474 35.2 150 121 160 143 463 
0.25 12.8 23.9 95.8 131 218 792 42.7 71.5 92.3 255 
0.5 102 142 147 206 61.7 91.1 156 189 117 157 
1 57.1 78.8 178 230 62.3 84.8 91.8 147 97.3 135 
2 76.7 90.7 45.9 60.4 111 135 48.2 55.3 70.5 85.4 
3D
 O
SE
M
 0.125 254 498 60.4 220 15.9 37.9 91.8 871 106 407 
0.25 17.3 31.5 152 207 165 627 36.3 63.3 92.7 232 
0.5 90.9 133 67.3 93.2 63.4 91.4 147 188 92.2 126 
1 49.9 67.8 123 171 64.8 92.5 112 182 87.4 128 
2 82.2 94.6 47.4 63.3 106 132 63.6 75.4 77.3 91.3 
Mean 114 176 131 278 77.5 164 77.7 220 100 210 
* No ROI drawn by human observers for this set 
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Figure 16:  Each graph plots the average volumes (mL) of the ROIs drawn by the observers 
versus the average TBRs in these ROIs.  Diamonds represent uncorrected TBRs and 
triangles represent corrected TBRs.  Error bars for these points represent the standard 
deviation of the average TBR (vertical bars) and ROI volume (horizontal bars).  Dotted 
lines connect the plotting symbols to the corresponding true lesion volumes and TBRs 
(blue long-dashed lines).  The red short-dashed horizontal line represents a TBR of 2.5. 
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Table 25:  Percent recovered TBR, averaged over all actual TBRs and lesion sizes 
 2D FBP 3D FBP 2D OSEM 3D OSEM 
ROIs, as drawn 129 ± 106 144 ± 146 109 ± 77.0 113 ± 77.6 
Dilated ROIs 111 ± 88.4 104 ± 88.3 91.0 ± 56.5 90.0 ± 57.1 
Eroded ROIs 184 ± 192 291 ± 456 155 ± 157 197 ± 218 
 
Table 26:  Az values using pooled data for the LDS 
PET PET/CT PET PET/CT 
Nuclear medicine physicians All physicians 
0.68 ± 0.04 0.72 ± 0.04 0.63 ± 0.03 0.77 ± 0.03 
Radiation  oncologists Medical physicists 
0.59 ± 0.5 0.81 ± 0.04 0.67 ± 0.04 0.75 ± 0.04 
 
Table 27:  Az  values using pooled data for the MLCS 
PET PET/CT PET PET/CT 
Nuclear medicine physicians All physicians 
0.74 ± 0.04 0.80 ± 0.04 0.71 ± 0.03 0.83 ± 0.03 
Radiation  oncologists Medical physicists 
0.67 ± 0.05 0.87 ± 0.03 0.82 ± 0.09 0.90 ± 0.05 
 
Table 28:  Percent sensitivity, specificity, and accuracy using PET/CT data for the LDS 
PET PET/CT 
Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
Nuclear medicine physicians 
34.0 ± 4.2 100 ± 0.0 50.5 ± 3.2 34.6 ± 4.2 97.1 ± 0.0 50.5 ± 3.2 
Radiation oncologists 
21.2 ± 3.4 100 ± 0.0 40.9 ± 2.6 25.0 ± 3.7 100 ± 0.0 43.8 ± 2.8 
All physicians 
27.6 ± 2.7 100 ± 0.0 45.7 ± 2.0 29.8 ± 2.8 99.0 ± 0.0 47.1 ± 2.1 
Medical physicists 
20.5 ± 3.4 100 ± 0.0 40.4 ± 2.5 22.4 ± 3.5 100 ± 0.0 41.8 ± 2.6 
 
Table 29:  Percent sensitivity, specificity, and accuracy using PET/CT data for the MLCS 
PET PET/CT 
Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy 
Nuclear medicine physicians 
23.8 ± 5.0 97.7 ± 0.0 69.2 ± 1.9 23.8 ± 5.0 100 ± 0.0 70.7 ± 1.9 
Radiation oncologists 
35.0 ± 6.0 97.7 ± 0.0 73.6 ± 2.3 26.2 ± 5.2 99.3 ± 0.0 71.2 ± 2.0 
All physicians 
29.4 ± 3.9 97.7 ± 0.0 71.4 ± 1.5 25.0 ± 3.6 96.1 ± 0.0 70.9 ± 1.4 
Medical physicists 
13.8 ± 3.9 100 ± 0.0 66.8 ± 1.5 12.5 ± 3.8 100 ± 0.0 66.3 ± 1.4 
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Figure 17:  Data for the LDS using PET data alone (black symbols) and PET/CT data (red 
symbols).  Lines connecting symbols (PET data:  dashed black line; PET/CT data: dashed 
red line) are for visual aid only as the data are not continuous.  First, second, third, and 
fourth decision thresholds correspond to the asterisk, diamond, triangle, and square 
shapes, respectively.  Black lines and red lines are fitted ROC curves representing studies 
without and with correlated CT images, respectively. 
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Figure 18:  Data for the MLCS using PET data alone (black symbols) and PET/CT data (red 
symbols).  Lines connecting symbols (PET data:  dashed black line; PET/CT data: dashed 
red line) are for visual aid only as the data are not continuous.  First, second, third, and 
fourth decision thresholds correspond to the asterisk, diamond, triangle, and square 
shapes, respectively.  Black lines and red lines are fitted ROC curves representing studies 
without and with correlated CT images, respectively. 
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CHAPTER 6:   
CONCLUSION 
PET images of single pulmonary nodules should be corrected for PVE.  PVE correction 
results in better diagnostic performance, reduced inter-observer variability, and increased 
quantitative accuracy of PET data.   
In this study, the PVE correction resulted in many more actually malignant cases being 
labeled as malignant at the cost of a slight increase in the number of actually benign cases being 
labeled as malignant.  In other words, observers, when using PVE correction, were much better 
at finding disease and a little worse at ruling out disease than when they were not using PVE 
correction. 
In this study, the medical physicists had much less experience evaluating PET/CT images 
than the physicians.  Thus, as expected, the physicians outperformed the medical physicists when 
using uncorrected TBRs.  However, when using corrected TBRs, the medical physicists 
performed similarly to the physicians.  This suggests that PVE correction makes evaluating PVE 
a less subjective task than when not using PVE correction, thus reducing inter-observer variation. 
PVE correction is more important than selection of reconstruction algorithm and acquisition 
mode.  In this study 3D OSEM allowed for the best diagnostic performance when PET data was 
displayed alone.  However when PET and CT data were displayed with and without PVE 
correction, no selection of reconstruction algorithm and acquisition mode outperformed any 
other.  Thus the selection of acquisition mode and reconstruction algorithm should be made 
based on factors other than diagnostic performance.  For instance, if the main factor in selection 
of acquisition mode is the length of time required to acquire a PET image, 3D mode should be 
used because of its increased sensitivity.  This finding also implies that the capability for 2D 
versus 3D acquisitions may not be a critical issue when purchasing new equipment if PVE 
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correction is used.  Selection of reconstruction algorithm could depend on a physician’s 
preference based on his or her familiarity with the selected algorithm or based on an expectation 
that the PET images alone may be used for some other diagnostic purpose. 
6.1 FUTURE DIRECTION 
Extensions of this work include: 
1. Expanding this work with more observers and more image data to further clarify the 
results of this study 
2. Evaluation of the influence of PVE correction on diagnostic performance regarding 
human PET images for a variety of possible medical conditions 
3. Finding the optimal method of PVE correction in terms of diagnostic performance 
regarding human PET images for a variety of possible medical conditions 
The statistical significance of many of the conclusions found in this study regarding 
acquisition mode and reconstruction algorithm were lacking because of the combination of low 
populations of observers and images.  Also, because of a lack of true and false positives, fitted 
curves could not be found for some of the ROC data.  Expanding this work with more observers 
and image data would further clarify the results found in this study.  Logistically, expanding this 
work could be difficult.  Evaluation of the 104 image sets took around six hours per observer; 
reducing standard deviations by one half would require roughly four times as many data sets or 
observers.   
 Evaluating the influence of PVE correction on diagnostic performance of experienced 
observers regarding human PET images would be a natural extension of this work.  Results 
found in this study were promising enough to suggest that PVE correction should be used with 
human PET images.  However, the efforts to collect the relevant image data are time 
consuming.  These efforts include obtaining information on the true condition of the patient.  It 
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may be impossible to determine the true tumor uptake unless some other independent method is 
employed, such as lesion biopsy.  Also, determining the true state of disease often requires 
following the patient for several years.  Although a data set for PET and CT images was 
recently published (29), the PET and CT images had been acquired on separate scanners; this 
data set preceded the common use of PET/CT.  An equivalent PET/CT data set would take an 
amount of time to accumulate that is prohibitive in terms of a Masters research project. 
The second extension of this work is suggested because any given method of PVE correction 
may not be suitable for all possible medical conditions.  For instance, the method of PVE 
correction used in this study is suitable only for lesions with homogenous radiotracer uptake that 
are surrounded by a structure with homogenous radiotracer uptake.  This method would not be 
suitable for necrotic lesions with heterogeneous radiotracer uptake, where a pixel-by-pixel 
correction would be more suitable, or for lesions surrounded by two different structures, where 
the geometric transfer matrix method would be more suitable. 
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